about
Selective blockade by nicergoline of vascular responses elicited by stimulation of alpha 1A-adrenoceptor subtype in the ratVascular permeabilization by intravenous arachidonate in the rat peritoneal cavity: antagonism by antioxidantsScreening for bipolar disorder in patients consulting general practitioners in France.Calcium dobesilate in the treatment of diabetic retinopathy.Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholismTherapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent.Therapeutic perspectives on uricases for gout.Novel drug discovery strategies for gout.AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.Cadmium and membrane ion transport in a French urban male population.The erythrocyte Na,K,Cl cotransporter and its circulating inhibitor in Dahl salt-sensitive rats.What can we learn from erythrocyte Na-K-Cl cotransporter NKCC1 in human hypertension?Evidence for a major route for zinc uptake in human red blood cells: [Zn(HCO3)2Cl]- influx through the [Cl-/HCO3-] anion exchanger.Verapamil reverts acute renal functional impairment induced by angiotensin II converting enzyme inhibitors.Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.Impact of an educational program on the management of bipolar disorder in primary care.Natriuretic effect of equol.Vaccinating against depression or anxiety: is it plausible?Antioxidant-Angioprotective Actions of Calcium Dobesilate in Diabetic Rats.A kinetic study of the Na pump in red cells: its relevance to the mechanism of active transport.Na+ leak in erythrocytes from essential hypertensive patients.Stimulation of K+ fluxes by diuretic drugs in human red cells.Outward sodium and potassium cotransport in human red cells.Inherited defect in a Na+, K+ -co-transport system in erythrocytes from essential hypertensive patientsErythrocyte Na+ and K+ transport systems in children with Bartter syndrome: increase in passive sodium permeabilityA circulating inhibitor of the RBC membrane calcium pump in chronic renal failureEvidence for the O-sulfo derivative of MK-447 as active metabolite of MK-447Inhibition of the erythrocyte Na+, K+-pump by mammalian lignansAn Na+-stimulated Mg2+-transport system in human red blood cellsInteraction between K+-transport, membrane potential and prostacyclin generation in the regulation of natriuresisEvidence for imbalanced furosemide-sensitive Na+, K+ cotransport in hereditary stomatocytosisA Na+,K+ co-transport assay for essential hypertensionReduction by (-)-cicletanine of the vascular reactivity to angiotensin II in ratsIs a K+-prostacyclin interaction involved in the mechanism of action of some diuretic drugs?Renal and vascular actions of equol in the ratInhibition of choroidal angiogenesis by calcium dobesilate in normal Wistar and diabetic GK ratsThe development of glutamate-based antidepressants is taking longer than expectedPharmacotherapeutic approaches to treating depression during the perimenopause
P50
Q28137656-D70B2D4E-F664-498B-B8CC-2DDBEA4FD130Q28195601-1CA8F0DF-CACF-4C8B-A670-E80B2210C83BQ30484734-5B7D1834-8778-4AC8-BC8A-96635863FC75Q30858537-3A54216F-A1DC-4AD3-9431-2E2E4C530A9AQ33548809-A8D2A32C-9E9F-457A-8FF3-E3FB02F51958Q36506194-59EF5BEC-A66D-4A01-BBFF-F6AE7C89C4C4Q37988242-57202649-D08F-4EE8-B065-A9C0AEBF3787Q38066561-78486A49-ED8D-4322-AB7D-00AC4145B831Q39034436-118AAF9E-3593-4C2F-A6E8-1380D38EC711Q39243215-F37CC77E-604B-4F6D-9657-E927E66822B3Q42463934-64A5F7E5-FFE2-4964-8CA2-B27866E8A360Q42520317-1E0AEDDE-ECEF-4F76-9C11-81DECE11454DQ43705476-69754923-1C9B-4A76-BF9A-155FA84FC744Q44629540-2C4ED334-8966-4C36-8E56-6C32683B8AC3Q44974869-04D1A305-22A3-48F8-96C6-4AD6EFDCA671Q46806892-AB09B588-FFE6-4C9A-BABE-2A6DEB3081B5Q47837348-34AC6A15-5B29-47D0-9C82-836395D95154Q47950332-54B82507-6347-4E09-95B2-70E218BE7742Q50521344-66310D08-645A-4A1C-9C34-9AF63E13F9ACQ52922895-24959A59-C940-4FF2-82C6-F9D9F341696BQ54441582-C2E337D0-EBF4-4B29-9DB5-EE533BD73D72Q54471676-E44CCFA9-7DF1-4B82-825D-85E27A3F1964Q54540506-CB61B076-BFC3-4133-B10B-0398A4D385FAQ59079695-E3B5B8B6-3BA9-4A5B-AA42-FF5731C3C488Q67287349-3840AE7B-0B70-4D1F-92B5-C556D7A536A4Q67508446-D1A53EB9-86C5-46A7-A54E-E42BD3632CA4Q68270300-3A633882-CA1B-41E2-A570-071CC964BEAAQ68966938-1E4EEAD1-D29A-4D86-AEDB-131339DB9EE1Q70026502-EF0E74B5-C873-40F8-8DA9-B35E7893620FQ70412570-81E2D9C0-6A24-46DB-8C6F-3F31F1D044BAQ71122440-5D28E814-5284-45EF-B534-0CB1B814B64CQ71469597-1BA9EE4A-525F-4F7D-ACCB-5DAA4B7F9C16Q71726607-5CDF50A1-E44E-4A73-BADA-12C8FB0D6F4DQ72553632-EE6E8860-2ACE-44E4-B726-2FB27E9EA4DAQ73909128-8D58BEBF-5EEE-4EBF-9300-C35D309984ABQ81459989-003C5EE7-4A17-4D3D-9C6D-FDA5CC3B7FDFQ87949076-0D94DB7D-989A-459C-906D-36CB78C7120FQ92246503-5A9C99AB-998E-4450-BE3E-8EE3F6417A41
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ricardo P Garay
@ast
Ricardo P Garay
@en
Ricardo P Garay
@es
Ricardo P Garay
@nl
Ricardo P Garay
@sl
type
label
Ricardo P Garay
@ast
Ricardo P Garay
@en
Ricardo P Garay
@es
Ricardo P Garay
@nl
Ricardo P Garay
@sl
prefLabel
Ricardo P Garay
@ast
Ricardo P Garay
@en
Ricardo P Garay
@es
Ricardo P Garay
@nl
Ricardo P Garay
@sl
P106
P21
P31
P496
0000-0001-6209-926X